Fortrea

Will your current (or upcoming) global clinical development program need a Diversity Action Plan? We’re evaluating the FDA’s latest Diversity Action Plan draft guidance and sharing our thoughts: https://lnkd.in/ecxtejMk #diversityinclinicaltrials #diversityequityandinclusion #diversityinhealthcare #healthequity #advancinghealthequity #clinicaltrials #clinicalresearch

Count on Fortrea to consistently recruit and deliver full healthy volunteer panels as planned. As with our 3 other CRU’s, the Daytona Beach Clinical Research Unit benefits from a dedicated team of recruiters and a significant database of potential participants ready to undergo screening for your protocol. With over 30 years’ experience in the field, Fortrea delivers a comprehensive suite of pharmacology services to manage every step of your early clinical development. https://lnkd.in/evrc_FFa #clinicaltrials #clinicalresearch

At Fortrea, we believe successful clinical trials hinge on collaboration. Our site partners bring invaluable expertise to the table, ensuring trial designs are achievable and patient-centric. We understand an unexecutable trial benefits no one. That’s why we prioritize creating a seamless clinical trial experience. We focus on removing obstacles and empowering sites to excel at what they do best – providing exceptional patient care. In recognition of this work, Fortrea has been nominated for the prestigious SCRS Eagle Award! We would be incredibly grateful if you would take a moment to vote. Your voice matters! https://lnkd.in/dh_HS9U6 Voting closes July 31. Thank you! #SCRSeagleaward #clinicalresearchsites #ClinicalTrials #SitePartnerships

Welcome to Fortrea’s clinical research unit in Daytona Beach, Florida. Our purpose-built phase one unit has an 88-bed capacity with telemetry coverage of the entire unit and an investigator team with more than 30 years of combined phase one experience. https://lnkd.in/evrc_FFa #clinicaltrials #clinicalresearch

Join our upcoming webinar on Patient Centricity in Neurodegenerative Diseases on July 11th and learn how to integrate patient-centric approaches in clinical research. Neurodegenerative diseases have a profound impact on patients, caregivers, and healthcare systems. While advancements have been made, there's a critical need to amplify patient and caregiver voices throughout the research journey. This webinar brings together experts from pharma and patient advocacy groups to discuss: • Patient-centric precision medicine • The crucial role of biomarkers in treatment development • Why patient & caregiver input matters in clinical trial design and execution Register now and ensure patients are at the forefront of research! https://lnkd.in/ehUt-mD7 #CNS #NeurodegenerativeDisorders #PatientCentricity #DigitalBiomarkers #ImagingBiomarkers #ClinicalTrialEndpoints #COA #Parkinsons #Alzheimers #ClinicalTrials #PrecisionMedicine

Join our upcoming webinar on Patient Centricity in Neurodegenerative Diseases on July 11th and learn how to integrate patient-centric approaches in clinical research. Neurodegenerative diseases have a profound impact on patients, caregivers, and healthcare systems. While advancements have been made, there's a critical need to amplify patient and caregiver voices throughout the research journey. This webinar brings together experts from pharma and patient advocacy groups to discuss: • Patient-centric precision medicine • The crucial role of biomarkers in treatment development • Why patient & caregiver input matters in clinical trial design and execution Register now and ensure patients are at the forefront of research! https://lnkd.in/ehUt-mD7 Speakers: Vikas Mohan Sharma, MD, Global Head of Neuroscience and Ophthalmology, Fortrea (Moderator); William Potter, MD, PhD, Independent expert (retired from NIMH, Lilly, and Merck); Hartmuth Kolb, PhD, CSO, Enigma Biomedical Group (EBG); Shana Dodge, PhD, Director of Research Engagement at the Association for Frontotemporal Degeneration (AFTD) #CNS #NeurodegenerativeDisorders #PatientCentricity #DigitalBiomarkers #ImagingBiomarkers #ClinicalTrialEndpoints #COA #Parkinsons #Alzheimers #ClinicalTrials #PrecisionMedicine

Neuroscience is a challenging therapeutic area. Not only are patients hard to find, but subjective assessments of neurological and psychiatric conditions, increased compliance risk and disparate data contribute to the complexity of neuroscience trials.

Joseph thrives at Fortrea! He witnessed incredible teamwork across departments like CTL and IHCRA, leading to successful recruitment in Taiwan. This collaborative spirit is just one aspect of Joseph's rewarding experience. His line manager recognized his potential and assigned him a novel study, expanding his skillset. Fortrea also prioritizes work-life balance, offering a flexible environment and a smooth onboarding process. Ready to launch your CRA career? Apply now! https://lnkd.in/et7bRPsJ

With 37 Diversity Action Plans supported to date, Fortrea Regulatory Strategy Consulting is closely tracking the latest FDA draft guidance on Diversity Action Plans. Learn about our ongoing efforts to meaningfully improve the diversity of clinical trial participants in global studies: https://lnkd.in/e47ZtePa #diversityinclinicaltrials #diversityequityandinclusion #diversityinhealthcare #healthequity #advancinghealthequity #clinicaltrials #clinicalresearch

We’re able to scale and give customers more versatile staff in roles and maybe do some things a little bit nontraditionally, which actually decreases handoff and in the end, it effectively reduces white space. https://lnkd.in/efTmR6-a #clinicaltrials #clinicalresearch